PEGylated Drugs Report

By www.reliablemarketforecast.com

Report Details

Report Name

Global PEGylated Drugs Market Research Report 2024 Story

Pages

90

Price

$ 2900

Features

PEGylated Drugs Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              AstraZeneca|||Bayer Healthcare|||Biogen|||BioMarin Pharmaceutical Inc|||Coherus BioSciences|||Enzon|||Horizon Therapeutics|||Leadiant Biosciences, Inc.|||Merck|||Mylan|||Novo Nordisk|||Pfizer|||Roche|||Sandoz|||Servier Pharmaceuticals LLC|||Takeda Pharmaceutical Company Limited            

Countries Covered

              "United States"|||"Canada"|||"Germany"|||"France"|||"UK"|||"Italy"|||"Russia"|||"Mexico"|||"Brazil"|||"Turkey"|||"Saudi Arabia"|||"UAE"|||"China"|||"Japan"|||"South Korea"|||"India"|||"Australia"            

Regions Covered

              "North America"|||"Europe"|||"Asia-Pacific"|||"Latin America"|||"Middle East & Africa"|||"Nordic Countries"            

Prices

Single User License:

$ 2900

Multi User License:

$ 4350

Enterprise/Corporate User License:

$ 5800